1. Introduction {#sec1-molecules-23-01417}
===============

Root and stem rot diseases of conifers cause huge economic losses, and are substantial problems for forestry. Several fungal species can cause root and stem rot, but several basidiomycete species of the genus *Heterobasidion* are, by far, the most widespread and destructive pathogens \[[@B1-molecules-23-01417]\]. Their initial route of spread and infection is by airborne basidiospores that infect freshly cut stump surfaces or wounds on the roots or stem. Following stump colonization, the pathogen grows down through the root system, and can spread efficiently to adjacent healthy trees by root-to-root contact \[[@B2-molecules-23-01417]\].

*Phlebiopsis gigantea* (Fr.) Jülich, is a saprophytic basidiomycete fungus used as a biocontrol agent to prevent *Heterobasidion* root rot. Biocontrol with *P. gigantea* is accomplished by applying arthroconidia (oidia) of the fungus to the stump surface soon after felling of a tree. Thor and Stenlid \[[@B3-molecules-23-01417]\] have shown that this biocontrol treatment is highly efficient, and may reduce *Heterobasidion* stump infections by 88--99% compared with untreated stumps. Rotstop^®^, a commercial biocontrol product based on *P. gigantea*, is commonly (\>47 000 ha annually) used in forestry in the Nordic countries \[[@B4-molecules-23-01417]\]. However, very little is known about the mechanism of the biocontrol action. Research has been focused on upregulated genes during interaction between *P. gigantea* and *Heterobasidion* spp. \[[@B5-molecules-23-01417]\], induced resistance barriers, and metabolites accumulated by the host due to prior colonization of *P. gigantea* on stumps \[[@B4-molecules-23-01417]\] etc., but very little of the research efforts have been focused on the impact of secondary metabolites produced by *P. gigantea* on *Heterobasidion* spp. Only 2′,3′,5′-trimethoxy-*p*-terphenyl has previously been reported to be produced by *P. gigantea* \[[@B6-molecules-23-01417]\], but the biological activity of this compound has not been examined. However, some other *p*-terphenyls have been shown to have biological activities, e.g., antifungal, antibacterial, antioxidant, and cytotoxic \[[@B7-molecules-23-01417],[@B8-molecules-23-01417]\].

The objective of the present study was to investigate the production of secondary metabolites by *P. gigantea*, and to test whether these compounds have an effect on *Heterobasidion*, and thus, could be involved in the in vivo biocontrol interactions between *P. gigantea* and *Heterobasidion* species. The paper describes the isolation and characterization of five compounds, of which three were new diarylcyclopentenones, one was a new *p*-terphenyl natural product, and one was the known compound *o*-orsellinaldehyde. Additionally, the biosynthesis of the compounds is discussed.

2. Results and Discussion {#sec2-molecules-23-01417}
=========================

2.1. Isolation of Compounds {#sec2dot1-molecules-23-01417}
---------------------------

A four liter liquid culture of *P. gigantea* was subjected to solid-phase extraction (SPE) resulting in a 20% CH~3~CN extract and a 95% CH~3~CN extract. Each extract was fractionated by semi-preparative RP-HPLC and fractions corresponding to major UV peaks were collected and dried, resulting in the isolation of five compounds. Compounds **1** and **2** were found in the 20% CH~3~CN extract and compounds **3** and **4**, and *o*-orsellinaldehyde, were obtained from the 95% CH~3~CN extract.

2.2. Structure Determination {#sec2dot2-molecules-23-01417}
----------------------------

The structures of the compounds ([Figure 1](#molecules-23-01417-f001){ref-type="fig"}) were elucidated using data from liquid chromatography---high-resolution mass spectrometry (LC-HRMS) and NMR spectroscopy. The supporting 1D and 2D NMR spectra and HRMS data for compounds **1**--**4** are presented in the [supplementary material file](#app1-molecules-23-01417){ref-type="app"}. The ^1^H- and ^13^C-NMR data for compounds **1**--**3** are presented in [Table 1](#molecules-23-01417-t001){ref-type="table"}, and for compound **4** in [Table 2](#molecules-23-01417-t002){ref-type="table"}, while key heteronuclear multiple-bond correlations (HMBC) and rotating-frame Overhauser enhancement spectroscopy (ROESY) correlations are given in [Figure 2](#molecules-23-01417-f002){ref-type="fig"}. *o*-Orsellinaldehyde was identified by HRMS and ^1^H-NMR by comparison with literature data \[[@B9-molecules-23-01417]\].

Compound **1** had the molecular formula C~18~H~14~O~5~, based on LC-HRMS analysis, corresponding to an unsaturation index of 12. The one-dimensional ^1^H-NMR spectrum of **1** ([Table 1](#molecules-23-01417-t001){ref-type="table"}) in MeOH-*d*~4~ showed six signals in the aromatic region from, in total, ten hydrogens, with coupling patterns in agreement with two different non-substituted phenyl groups, and also a singlet signal at δ~H~ 4.76 from a methine group, which according to the carbon chemical shift (δ~C~ 80.8, C-4), should be oxygen linked. The two non-substituted phenyl rings contributed with eight to the calculated unsaturation index (12), leaving out four to a central moiety which must contain six carbons, four hydrogens and five oxygens. The multiplet at δ~H~ 8.01 (H-2′′/H-6′′) showed an HMBC correlation ([Figure 2](#molecules-23-01417-f002){ref-type="fig"}) to a carbon at δ~C~ 201.7 (C-6), placing a carbonyl group immediately adjacent to one of the phenyl rings. Similarly, the multiplet at δ~H~ 7.77 (H-2′/H-6′) from the second phenyl ring showed an HMBC correlation to an sp^2^ carbon next to that phenyl ring (δ~C~ 117.5, C-2). HMBC experiments further demonstrated that the isolated proton (δ~H~ 4.76, δ~C~ 80.8, H-4) was in the proximity of both C-2 and C-6. In addition to these HMBC correlations, H-4 also showed correlations to a carbon at δ~C~ 89.9 (C-5) and to a broad signal at 190.9 (C-1), probably from another carbonyl function.

Of the remaining four unsaturations, two were taken by the indicated carbonyl groups and one by the double bond to C-2, which means that compound **1** should contain a five-membered ring placed between one phenyl ring and one benzoyl moiety to fulfill the unsaturation index. Since only one of the remaining four hydrogens gave signals in the ^1^H-NMR spectrum (MeOH-*d*~4~), compound **1** must contain three hydroxyl groups placed on the five membered ring. Of the six carbons in the central moiety, only five gave signals in the ^13^C-NMR spectrum---the signal for C-3 was missing. The broad nature of the C-1 signal and its relatively low chemical shift, plus the missing signal of C-3 could be explained by a β-hydroxylated-α,β-unsaturated keto function, which interconverts by tautomerization. Alternatively, the broad signal at 190.9 includes both the signal of C-1 and C-3. Finally, the two remaining hydroxyl groups could be placed on C-4 and C-5. In THF-*d*~8~, these two hydroxyl protons resonated at δ~H~ 6.02 and δ~H~ 5.18, 5-OH, and 4-OH, respectively, as assigned by a COSY correlation between H-4β and 4-OH. There was a ROESY correlation between H-4β and 5-OH ([Figure 2](#molecules-23-01417-f002){ref-type="fig"}). Energy minimized models of **1** with *trans* and *cis* relation between 5-OH and 4-OH were compared. In *trans*-**1**, the distance H-4β/5-OH was 2.2 Å, and the 5-OH/4-OH distance was 3.5 Å, whereas in *cis*-**1**, the distances were 3.0 Å and 2.8 Å, respectively. The presence of a ROESY correlation between H-4β and 5-OH, but not between 5-OH and 4-OH, fits the *trans* configuration better, and thus, the structure of compound **1** was concluded to be as shown in [Figure 1](#molecules-23-01417-f001){ref-type="fig"}, whereby **1** was named phlebiopsin A.

LC-HRMS analysis established the molecular formula for compound **2** to be C~17~H~12~O~4~ corresponding to an unsaturation index of 12. The ^1^H-NMR ([Table 1](#molecules-23-01417-t001){ref-type="table"}) spectrum of compound **2** in MeOH-*d*~4~ was overall similar to the spectrum of compound **1**, although a signal equivalent to H-4 of compound **1** was missing. Signals from ten protons in the region δ~H~ 7.3--7.6, suggested that two non-substituted phenyl rings were present just as in compound **1**. Correlation spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), and HMBC data were used to assign the corresponding sp^2^ carbon signals in the ^13^C spectrum. In addition to the aromatic carbons, the ^13^C spectrum contained signals from two carbonyls (δ~C~ 199.8 and 199.0), two olefinic carbons (δ~C~ 167.6 and 130.6) and one quaternary carbon (δ~C~ 77.9). These findings contributed with further three unsaturations to the eight accounted for by the phenyl rings, leaving out one (unsaturation index 12) to a five-membered ring, similar to compound **1**. HMBC ([Figure 2](#molecules-23-01417-f002){ref-type="fig"}) displayed correlations between H-2′/H-6′ and one of the olefinic carbons (δ~C~ 130.6, C-2) and between H-2′′/H-6′′ and the quaternary carbon (δ~C~ 77.9, C-5). Consequently, the remaining olefinic carbon (δ~C~ 167.6) and two carbonyls are part of the five-membered ring, and by comparing with the molecular formula, the five-membered ring should be substituted by two hydroxyl groups. The structure proposed for compound **2** is the only one that fits these data, except for the other tautomer. A ^1^H-NMR spectrum of compound **2** was also recorded in THF-*d*~8~, showing a proton signal at δ~H~ 5.99 from the hydroxyl group at C-5. Furthermore, HMBC correlations between 5-OH and C-5, C-1′′, C-4, and a weak correlation between 5-OH and C-1, further strengthened the proposed structure of compound **2**. Compound **2** was given the name phlebiopsin B. Phlebiopsin B is very similar to gyroporin \[[@B10-molecules-23-01417]\], which has two *p*-hydroxyphenyl groups instead of two phenyl groups as in **2**.

LC-HRMS data of compound **3** established the molecular formula as C~18~H~14~O~4~, thus implying 12 unsaturations. Judged by the molecular formula, a structure with similarities to compound **1** and **2** was expected. Evidently, the ^1^H-NMR spectrum in THF-*d*~8~ of compound **3** contained several multiplets between δ~H~ 7.13 and 8.11. However, these signals integrated for nine protons and not ten as in both compound **1** and **2**, thus, suggesting an additional substituent on one of the phenyl rings. Assisted by HSQC data, one methylene (δ~H~ 5.61/5.50, d, 13.6 Hz, 2′-CH~2~), two hydroxyl groups (δ~H~ 5.45, s, 5-OH, and δ~H~ 4.61, d, 6.6 Hz, 4-OH) and one methine group (δ~H~ 4.69, d, 6.6 Hz, H-4) were identified in the ^1^H-NMR spectrum. From HMBC experiments ([Figure 2](#molecules-23-01417-f002){ref-type="fig"}), it was found that the hydroxyl group at δ~H~ 5.45 (5-OH) was in the vicinity of a carbonyl carbon (δ~C~ 198.7, C-1), an sp^2^ carbon (δ~C~ 141.6, C-1′′), a quaternary carbon (δ~C~ 86.0, C-5), and a methine group (δ~C~ 78.0, C-4). Furthermore, both H-4 and the other hydroxyl group (4-OH) displayed HMBC correlations to a carbon at δ~C~ 182.4 (C-3) and to C-5. In addition, H-4 had an HMBC correlation to a carbon at δ~C~ 114.1 (C-2). It was also observed by HMBC experiments that H-2′′/H-6′′ was within three bonds from C-5. Altogether, the HMBC data suggested this part of the molecule to be an α,β-unsaturated cyclopentenone ring linked via C-5 to a non-substituted phenyl ring and hydroxylated at C-4 and C-5, similar to compound **1**, but without the carbonyl joining the phenyl and the pentenone ring. The relation of the two hydroxyl groups were also proposed to be the same as in compound **1**, that is *trans*, based on an observed ROESY correlation between 5-OH and H-4. On the other side of the cyclopentenone ring, an HMBC correlation was observed between H-6′ and C-2 that connected the second phenyl ring with the cyclopentenone ring. HMBC data also demonstrated that a methylene bridge must be present based on correlations from the methylene at δ~H~ 5.61/5.60 (2′-CH~2~) to C-3, C-1′, C-2′, and C-3′. Thus, the last unsaturation could be attributed to another ring and fulfill the unsaturation index (12), and finally, the structure of compound **3** could be proposed. Compound **3** was given the name phlebiopsin C.

Compounds **2** and **3** are hydroxylated 2,5-diarylcyclopentenones and compound **1** has a related structure. The 2,5-diarycyclopentenones is a group of compounds that are rarely found in nature, and they have been described as characteristic constituents of certain mushrooms of the order Boletales, and responsible for the bluing reactions observed when the fungal fruit bodies are exposed to mechanical injury. Examples include gyrocyanin and gyroporin isolated from *Gyroporus cyanescens* \[[@B10-molecules-23-01417]\] and *Chamonixia caespitosa* \[[@B11-molecules-23-01417]\], chamonixin from *C. caespitosa* \[[@B11-molecules-23-01417]\] and *Gyrodon lividus* \[[@B12-molecules-23-01417]\], as well as involutone and involutin from *Paxillus involutus* \[[@B13-molecules-23-01417],[@B14-molecules-23-01417],[@B15-molecules-23-01417]\]. However, the previous finding of the 2,5-diarylcyclopentenones sydowin A and B, in the ascomycete *Aspergillus sydowii* \[[@B16-molecules-23-01417]\], and now the finding of the 2,5-diarylcyclopentenones **2** and **3** in *P. gigantea*, order Polyporales, which is the first finding in a basidiomycete outside the order Boletales, show that these compounds are not exclusively produced in the order Boletales only.

Compound **4** was assigned the molecular formula C~25~H~26~O~8~, based on LC-HRMS data, corresponding to an unsaturation index of 13. The one-dimensional ^1^H-NMR spectrum in acetone-*d*~6~ contained signals from eleven protons linked to sp^2^ carbons between δ~H~ 6.7 and 7.6, a one-proton doublet CH signal at δ~H~ 4.81 (δ~C~ 104.6, C-1′′), several multiplet signals from six CH protons between δ~H~ 3.0 and 3.6, and a methoxy signal at δ~H~ 3.59 (δ~C~ 61.3, --OCH~3~). Data from COSY, TOCSY, HSQC, and HMBC experiments suggested the compound to be an analogue to terfestatin A \[[@B17-molecules-23-01417]\], with a methoxy group on the central aromatic ring instead of a hydroxyl function. This methoxy analogue of terfestatin A has previously been synthesized, and the NMR data for **4** ([Table 2](#molecules-23-01417-t002){ref-type="table"}) was in good agreement with literature values \[[@B18-molecules-23-01417]\]. However, the optical rotation for compound **4** (−43°) was different from what was reported for the synthesized compound (+128.8°) \[[@B18-molecules-23-01417]\], but was similar to what was reported for terfestatin A (−37.2°) \[[@B17-molecules-23-01417]\]. To avoid any ambiguities concerning absolute configuration, the glucose residue was analyzed by a diastereomeric resolution method, which clearly indicated that compound **4** had a [d]{.smallcaps}-glucopyranosyl residue. This is the first report on compound **4** as a naturally occurring compound, and the fully assigned NMR data is presented here for the first time ([Table 2](#molecules-23-01417-t002){ref-type="table"}). Compound **4** was given the name methyl-terfestatin A. One *p*-terphenyl compound, 2′,3′,5′-trimethoxy-*p*-terphenyl, has previously been reported from *P. gigantea* \[[@B6-molecules-23-01417]\], but this compound was not found in the present study.

Isotope labelling studies suggested more than 50 years ago the biosynthesis of *p*-terphenylquinones, such as polyporic acid and atromentin, to proceed by condensation of two molecules of phenylpyruvic acid or similar \[[@B19-molecules-23-01417]\]. Natural 2,5-diarylcyclopentenones, e.g., gyrocyanin, have been proposed to be formed by oxidative ring contraction of atromentin \[[@B10-molecules-23-01417]\], but only recently, genetic, transcriptomic, and chemical evidence were presented, showing that atromentin, indeed, was the direct precursor of gyrocyanin in *P. involutus* (Boletales) \[[@B20-molecules-23-01417]\]. It is possible that the cyclopentenone motifs of compounds **2** and **3** are formed in a similar way, but from polyporic acid via the putative monooxygenase generated epoxide **5** ([Figure 3](#molecules-23-01417-f003){ref-type="fig"}, route A). The cyclopentenone motif of compound **1** may originate from an alternate opening of epoxide **5** ([Figure 3](#molecules-23-01417-f003){ref-type="fig"}, route B), which would leave a keto function between the cyclopentenone group and one of the phenyl groups.

As mentioned above, there were difficulties in observing sharp ^13^C-NMR signals for carbon 1 and 3 in compound **1**, even though several different solvents and temperatures were tested (data not shown). By contrast, compound **2** and **3** showed excellent signals for the corresponding carbon atoms. An explanation could be that compound **1** interconverts by keto--enol tautomerization, whereas compound **2** and **3** are locked; compound **2** by intramolecular hydrogen bonding to the keto function at C-4, and compound **3** by the ether. Gyroporin, involutin, chamonixin, and sydowin A and B are compounds that show high degree of structural similarities with compound **1**--**3**. Their structures do all consist of a β-hydroxylated-α,β-unsaturated keto function, and thus, could be associated with tautomerism. Evidently, difficulties and/or notable chemical shifts have been observed for the signals of C-1 and C-3 for these structures. In sydowin A, for example, the chemical shifts for C-1 and C-3 were reported as 194.9 and 194.1, respectively, and the corresponding carbon atoms in sydowin B were never detected \[[@B16-molecules-23-01417]\]. Furthermore, Feling et al. \[[@B21-molecules-23-01417]\], were able to detect C-1 and C-3 in chamonixin, but not in involutin, even though the structures of these compounds only differ in a hydroxyl group in one of the phenyl rings. Involutin was also identified by Antkowiak et al. \[[@B15-molecules-23-01417]\], but in contrast to Feling et al. \[[@B21-molecules-23-01417]\], they were able to observe ^13^C signals for C-1 and C-3. In conclusion, these type of structures, with the inherent possibility of keto--enol tautomerization, seem to result in various levels of difficulty during the NMR analysis. The exact behavior of the compounds during analysis probably depends on factors such as solvent, pH, and temperature. In the case of compound **1**, many different NMR solvents and temperatures were tested with unsatisfactory results.

2.3. Biological Activities {#sec2dot3-molecules-23-01417}
--------------------------

Compounds **1**--**4** and *o*-orsellinaldehyde were tested against three species of fungi, including the basidiomycete *H. occidentale* and the ascomycetes *F. oxysporum* and *P. canescens*, for determination of minimal inhibitory concentration (MIC). *Heterobasidion occidentale* is a common pathogen of conifers, causing extensive economic losses. The other two fungal species represent model organisms, among which *F. oxysporum* is a common pathogen of many plant species, while *P. canescens* is a saprotroph. Compounds **1**--**4** were tested in concentrations from 400 μM down to 1 nM, whereas *o*-orsellinaldehyde was tested from 2 mM down to 1 nM. However, none of compounds **1**--**4** were able to inhibit the germination of fungal conidia at the tested concentrations. As mentioned above, compound **4** is very similar to terfestatin A, which has been characterized as a specific inhibitor of auxin signaling in plants \[[@B17-molecules-23-01417],[@B22-molecules-23-01417]\]. In a subsequent study, aimed at identifying the active core structure of terfestatin A, compound **4** was synthesized and also tested for inhibition of auxin signaling, resulting in the conclusion that the hydroxyl group at position C-3′ is critical for inhibition \[[@B18-molecules-23-01417]\]. Gliocladin B, also identified as a *p*-terphenyl β-glucoside, has been shown to inhibit the growth of two human tumor cell lines (HeLa and HCT 116), as well as having antimicrobial activity \[[@B23-molecules-23-01417]\]. It differs in structure from compound **4** by having methoxy groups at C-4 and C-4′′, and by a hydroxyl group at 3′, as terfestatin A, instead of a methoxy group.

In contrast to compounds **1**--**4**, *o*-orsellinaldehyde exhibited complete inhibition of conidial germination of *H. occidentale* down to 1 mM, and partial inhibition at 0.5 mM. Furthermore, *o*-orsellinaldehyde showed complete inhibition of conidial germination of both *P. canescens* and *F. oxysporum* at 2 mM and partial inhibition down to 1 mM. *o*-Orsellinaldehyde has never, as far as we know, been investigated regarding its antifungal activity, but it has been shown to be cytotoxic against a human carcinoma cell line (Hep 3B) and a lung fibroblast cell line (MRC-5) \[[@B24-molecules-23-01417]\].

The mode of action of *P. gigantea* in biocontrol of *Heterobasidion* spp. has previously been suggested to be by resource competition \[[@B5-molecules-23-01417]\] as the biocontrol agent is able to rapidly colonize the surfaces of fresh tree stumps, thereby making the niche suitable for *Heterobasidion* infections pre-occupied. The present study, with no antifungal activity found for compounds **1**--**4**, and rather weak activity for *o*-orsellinaldehyde, supports the suggested mode of action.

3. Materials and Methods {#sec3-molecules-23-01417}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-23-01417}
------------------------------------

Optical rotations were measured in CH~3~OH on Perkin-Elmer polarimeters models 341 and 343, using a 1 mL cell (path length 10.0 cm, λ 589 nm, 20 °C). UV spectra were recorded in CH~3~OH on a Hitachi U-2001 spectrophotometer. NMR spectra were recorded with Bruker Avance III 600 MHz spectrometers (Bruker Biospin GmBH, Rheinstetten, Germany), equipped with a 5 mm ^1^H/^13^C/^15^N/^31^P inverse detection CryoProbe or a 5 mm broadband observe detection SmartProbe, operated at 600 MHz for ^1^H-NMR and 150 MHz for ^13^C-NMR. NMR experiments were performed with MeOH-*d*~4~, acetone-*d*~6~, or THF-*d*~8~ as solvents, using pulse sequences supplied by Bruker to perform 1D ^1^H and ^13^C, and 2D ^1^H--^1^H COSY, ^1^H--^1^H TOCSY (80 ms), ^1^H--^13^C HSQC-DEPT, ^1^H--^13^C HMBC (65 ms), and ^1^H--^1^H ROESY (200 or 300 ms) experiments. Chemical shifts are reported relative to residual solvent signals (δ~H~ 3.31; δ~C~ 49.15 for MeOH-*d*~3~, δ~H~ 2.05; δ~C~ 29.92 for acetone-*d*~5~ and δ~H~ 3.58; δ~C~ 67.57 for THF-*d*~7~). LC-HRMS was performed on an HP1100 LC system (Hewlett-Packard, Palo Alto, CA, USA)) using a Reprosil-Pur ODS-3 column (C18, 5 μm, 4 × 125 mm, Dr. Maisch GmbH, Ammerbuch, Germany) connected to a Bruker maXis Impact mass spectrometer (Bruker Daltonic GmbH, Bremen, Germany) with an electrospray ion-source (ESI-QTOF). Calibration was performed prior to analysis with a sodium formate solution, and additionally, internally for each run by injecting the calibrant at the beginning of each run using a software controlled valve. Semi-preparative HPLC was run using a Gilson system, including a Gilson 305/306 pump, a Gilson 118 UV detector (λ 254 nm) and a Gilson FC204 fraction collector (Gilson Inc., Middleton, WI, USA).

3.2. Production of Fungal Cultures for Metabolite Isolation {#sec3dot2-molecules-23-01417}
-----------------------------------------------------------

*P. gigantea* strain Rotstop^®^ (Verdera Ltd., Esbo, Finland) was maintained on Melin Norkrans agar media (MMN; \[[@B25-molecules-23-01417]\]) in 9 cm diameter Petri dishes at room temperature (ca. 21 °C) in the dark. For the production of metabolites, 500 mL Erlenmeyer flasks were used, each containing 250 mL of liquid MMN media. Five agar plugs 0.5 × 0.5 cm in size with established fungal mycelia from an actively growing colony were aseptically inoculated in each flask, and incubated on a rotary shaker at 120 rpm at room temperature for seven weeks. Cultures were filtered to obtain a mycelium-free sample for sample work-up by reversed-phase SPE.

3.3. Production of Microbial Inoculums for Bioassay {#sec3dot3-molecules-23-01417}
---------------------------------------------------

The fungal isolates *H. occidentale* strain TC122-12, *F. oxysporum* strain 4S4-49b, and *P. canescens* strain 9P2-24a were obtained from the culture collection of the Department of Forest Mycology and Plant Pathology, Swedish University of Agricultural Sciences. The isolates were cultivated on MMN in 9 cm Petri dishes at room temperature (ca. 21 °C) in the dark. Fungal conidia were harvested from 15 day old cultures by flooding the mycelium with liquid MMN media, and gently rubbing the culture colony with a glass rod. Mycelial fragments were subsequently removed from the suspensions by filtration (50 µm mesh), and the conidial concentrations were determined using a haemacytometer.

3.4. Bioassay Procedure {#sec3dot4-molecules-23-01417}
-----------------------

Pure compounds **1**--**4** and *o*-orsellinaldehyde were dissolved in DMSO and transferred to wells in microtiter plates. Bioassays were performed using 100 µL of liquid MMN media containing 10^5^ conidia cells/mL of either *H. occidentale*, *F. oxysporum*, or *P. canescens* by adding respective suspensions to each well. The final concentration of DMSO was 1%. Negative control wells comprised conidia of each organism in liquid MMN media, and wells containing 10% DMSO were used as a positive control. As conidia of *P. canescens* and *F. oxysporum* germinate faster than conidia of *H. occidentale*, conidial germination for *P. canescens* and *F. oxysporum* was recorded after 65 h and for *H. occidentale* after 96 h of their inoculation and incubation at room temperature in darkness. The conidial germination and fungal growth was estimated by ocular observation of the microtiter plates using stereomicroscope, as well as by an automated plate reader (Labsystems Multiscan RC, Helsinki, Finland) operated at 620 nm. All biotests were performed in triplicate and repeated once.

3.5. Extraction and Isolation {#sec3dot5-molecules-23-01417}
-----------------------------

A four liter mycelium-free fungal culture of *P. gigantea* was extracted using eight 10 g Isolute C18 end-capped SPE columns. Prior to sample loading, the columns were activated with CH~3~OH (60 mL) and equilibrated with H~2~O (60 mL). The loaded columns were rinsed with 60 mL H~2~O to remove any non-bound substances before the lipophilic analytes were eluted in two steps, starting with 60 mL 20% aqueous CH~3~CN (eluate 1) followed by 95% aqueous CH~3~CN (eluate 2). The CH~3~CN of the two eluates were evaporated under reduced pressure, and the residues lyophilized, yielding 320 mg dry material of eluate 1 and 70 mg of eluate 2. The dry SPE extracts were dissolved in aqueous CH~3~CN (15% and 30% CH~3~CN for eluate 1 and 2, respectively) and subjected (4 × 1 mL injected of each eluate) to semipreparative reversed phase HPLC (Reprosil-Pur ODS-3, 5 μm, C18, 20 × 100 mm, with a guard column, 20 × 30 mm, 5 μm, Dr. Maisch GmbH). The column was eluted at 13.2 mL/min with aqueous CH~3~CN (0.2% formic acid), using the gradient 8--70% CH~3~CN in 50 min, 70--95% CH~3~CN in 5 min, and a hold at 95% for 5 min. The elution was monitored at 254 nm and fractions were collected in 2 mL 96-deep well plates. Fractions corresponding to major UV peaks were selected, pooled separately, and concentrated gently by nitrogen gas, and diluted 1:1 with H~2~O prior to small scale SPE extraction (Waters Oasis, HLB, 30 mg, 1 mL). The columns were activated (1 mL CH~3~OH) and equilibrated (1 mL H~2~O) before sample loading. Following sample loading, H~2~O was replaced by rinsing the SPE columns with D~2~O. The columns were subsequently eluted with either MeOH-*d*~4~ (compounds **1**--**2**) or chloroform-*d* (compounds **3**--**4**) directly into 5 mm NMR tubes. When necessary, NMR solvents were changed to acetone-*d*~6~ or THF-*d*~8~. LC-HRMS data were recorded using the same gradient and mobile phases as for the preparative system at 0.7 mL/min. Compounds **1** and **2** were isolated from the 20% CH~3~CN extract, whereas compounds **3** and **4** were isolated from the 95% CH~3~CN extract.

3.6. Relative Configuration of Compound ***1*** {#sec3dot6-molecules-23-01417}
-----------------------------------------------

Energy minimized models of compound **1** were calculated by using Chem3D Ultra ver. 16.0.1.4, with the MM2 force field (PerkinElmer Informatics Inc., Waltham, MA, USA). Subsequently, the relevant interatomic distances were measured using the same software.

3.7. Absolute Configuration of Compound ***4*** {#sec3dot7-molecules-23-01417}
-----------------------------------------------

Approximately 90 μg of compound **4** in MeOH (50 μL) was treated with 500 μL MeOH--acetyl chloride (10:1), and heated at 85 °C overnight, after which the mixture was dried by nitrogen gas. The residue was redissolved in 500 μL (*S*)-2-butanol-acetylchloride (10:1), and heated at 85 °C for 3 h. Reference samples consisting of methyl α-[d]{.smallcaps}-glucopyranoside, treated with both (*S*)-2-butanol and racemic 2-butanol, were prepared in the same manner. The resulting 2-butyl glycosides were dried by a stream of nitrogen gas, and subsequently silylated by adding 100 μL pyridine and 100 μL BSTFA--TMSCl, 99:1 (Sylon BFT, Supelco). The solutions were kept at room temperature overnight. Following dilution with ethyl acetate (1 mL) all samples were analyzed by GC-MS using a fused silica column (HP-5MS; 0.25 µm, 30 m × 0.25 mm, Agilent) with a temperature gradient (80 °C for 5 min, 80--250 °C at 5 °C/min, and a final hold at 250 °C for 5 min). The GC injector was held at 240 °C, and the GC-MS interface at 240 °C. Samples (1 µL) were injected in split mode (50:1), and helium was used as carrier gas (1 mL/min). This derivatization procedure results in a mixture of mainly 2-butyl α/β-glucopyranosides and the (*S*)-2-butyl and (*R*)-2-butyl glycosides of one of these anomeric forms are well separated by GC \[[@B26-molecules-23-01417]\]. The (*S*)-2-butyl [d]{.smallcaps}-glucopyranoside yielded one GC peak at t~R~ 32.82 min and the (*R*)-2-butyl [d]{.smallcaps}-glucopyranoside at t~R~ 33.08. The peak of the (*R*)-2-butyl [d]{.smallcaps}-glucopyranoside is chromatographically equivalent to the enantiomeric (*S*)-2-butyl [l]{.smallcaps}-glucopyranoside, representing a standard for identification of [l]{.smallcaps}-glucose.

The GC analysis of the (*S*)-2-butyl glycoside of compound **4** resulted in one major peak at t~R~ 32.85 min and one minor peak at t~R~ 33.11 min (ratio approx. 10:1, diastereomeric compound formed from contaminating (*R*)-2-butanol in the reagent), identifying the monosaccharide unit of compound **4** as [d]{.smallcaps}-glucose.

3.8. Phlebiopsin A *(**1**)* {#sec3dot8-molecules-23-01417}
----------------------------

Compound **1** was obtained as a yellowish oil; 0.36 mg; \[α\]${}_{D}^{20}$ +33.8 (*c* 0.04, CH~3~OH); UV (CH~3~OH) λ~max~(log ε) 381 (2.3), 274 (4.2), 203 (4.4) nm; ^1^H- and ^13^C-NMR in MeOH-*d*~4~, see [Table 1](#molecules-23-01417-t001){ref-type="table"}; HRMS *m/z* 311.0915 \[M + H\]^+^ (calcd for C~18~H~15~O~5~, 311.0914).

3.9. Phlebiopsin B *(**2**)* {#sec3dot9-molecules-23-01417}
----------------------------

Compound **2** was obtained as a yellowish oil; 1.03 mg; \[α\]${}_{D}^{20}$ −6.4 (*c* 0.09, CH~3~OH); UV (CH~3~OH) λ~max~(log ε) 353 (3.9), 273 (4.0), 246 (4.0), 203 (4.3) nm; ^1^H- and ^13^C-NMR in MeOH-*d*~4~, see [Table 1](#molecules-23-01417-t001){ref-type="table"}; HRMS *m/z* 281.0808 \[M + H\]^+^ (calcd for C~17~H~13~O~4~, 281.0808).

3.10. Phlebiopsin C *(**3**)* {#sec3dot10-molecules-23-01417}
-----------------------------

Compound **3** was obtained as a yellow-brownish oil; 1.29 mg; \[α\]${}_{D}^{20}$ −3.4 (*c* 0.12, CH~3~OH); UV (CH~3~OH) λ~max~(log ε) 288 (9.6), 254 (10.0), 205 (10.4) nm; ^1^H- and ^13^C-NMR in THF-*d*~8~, see [Table 1](#molecules-23-01417-t001){ref-type="table"}; HRMS *m/z* 295.0970 \[M + H\]^+^ (calcd for C~18~H~15~O~4~, 295.0965).

3.11. Methyl-Terfestatin A *(**4**)* {#sec3dot11-molecules-23-01417}
------------------------------------

Compound **4** was obtained as a yellow-brownish oil; 3.18 mg; \[α\]${}_{D}^{20}$ −43 (*c* 0.16, CH~3~OH); ^1^H- and ^13^C-NMR in acetone-*d*~6~, see [Table 2](#molecules-23-01417-t002){ref-type="table"}; HRMS *m/z* 477.1521 \[M + Na\]^+^ (calcd for C~25~H~26~NaO~8~, 477.1520).

**Sample Availability:***P. gigantea* is available from the authors.

The following are available online. ... 1D and 2D NMR spectra and HRMS data for compounds **1**--**4**.

###### 

Click here for additional data file.
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![Structures of compounds **1**--**4** and *o*-orsellinaldehyde. Relative configuration shown for compounds **1** and **3**.](molecules-23-01417-g001){#molecules-23-01417-f001}

![Key HMBC (solid arrows) and ROESY (dashed arrows) correlations for structure determination of compounds **1**--**3**.](molecules-23-01417-g002){#molecules-23-01417-f002}

![Proposed formation of compounds **1** and **2** from polyporic acid, via the monooxygenase generated intermediate **5**, and followed by two alternate openings of the epoxide (A and B).](molecules-23-01417-g003){#molecules-23-01417-f003}

molecules-23-01417-t001_Table 1

###### 

^1^H- and ^13^C-NMR data (600 and 150 MHz, respectively) for compounds **1**--**3** at 30 °C (**1**--**2** in MeOH-*d*~4~, and **3** in THF-*d*~8~).

             1              2                3                                              
  ---------- -------------- ---------------- --------------- ---------------- ------------- ----------------
  1          ^a^ 190.9, C   \-               ^b^ 199.8, C    \-               198.7, C      
  2          117.5, C       \-               ^c^ 130.6, C    \-               114.1, C      
  3          ^d^ n.d.       \-               167.6, C        \-               182.4, C      \-
  4          80.8, CH       4.76, s          ^b^ 199.0, C    \-               78.0, CH      4.69, d (6.6)
  5          89.9, C        \-               77.9, C         \-               86.0, C       \-
  6          201.7, C       \-               \-              \-               \-            \-
  1′         131.6, C       \-               ^c^ 130.37, C   \-               127.1, C      \-
  2′         129.3, CH      7.77, d (7.7)    130.41, CH      8.14, d (7.7)    127.7, C      \-
  3′         129.1, CH      7.37, t (7.7)    129.5, CH       7.47, t (7.6)    125.0, CH     7.13, d (7.5)
  4′         128.4, CH      7.27, t (7.7)    130.7, CH       7.41, t (7.5)    128.9, CH     7.24, obsc.
  5′         129.1, CH      7.37, t (7.7)    129.5, CH       7.47, t (7.6)    129.3, CH     7.28, t (7.5)
  6′         129.3, CH      7.77, d (7.7)    130.41, CH      8.14, d (7.7)    123.3, CH     8.11, d (7.5)
  1′′        138.1, C       \-               138.8, C        \-               141.6, C      \-
  2′′        131.0, CH      8.01, d (7.8)    127.1, CH       7.45, d (7.6)    128.6, CH     7.42, d (7.7)
  3′′        129.0, CH      7.43, t (7.8)    129.8, CH       7.37, t (7.5)    128.0, CH     7.23, obsc.
  4′′        133.7, CH      7.54, t (7.8)    129.7, CH       7.33, t (7.5)    127.72, CH    7.17, t (7.3)
  5′′        129.0, CH      7.43, t (7.8)    129.8, CH       7.37, t (7.5)    128.0, CH     7.23, obsc.
  6′′        131.0, CH      8.01, d (7.8)    127.1, CH       7.45, d (7.6)    128.6, CH     7.42, d (7.7)
  2′-CH~2~   \-             \-               \-              \-               72.6, CH~2~   5.61, d (13.6)
                                                                                            5.50, d (13.6)
  5-OH                      ^e^ 6.02, br s                   ^e^ 5.99, br s                 5.45, s
  4-OH                      ^e^ 5.18, br s                                                  4.61, d (6.6)

^a^ Broad signal, could include resonances for both C-1 and C-3; ^b^ May be interchanged; ^c^ May be interchanged; ^d^ Not detected, possibly overlapping with C-1; ^e^ Obtained in THF-*d*~8~.

molecules-23-01417-t002_Table 2

###### 

^1^H- and ^13^C-NMR data (600 and 150 MHz, respectively) for compound **4** at 30 °C in acetone-*d*~6~.

  pos.   *δ*~C~, mult.   *δ*~H~ (J in Hz)   pos.        *δ*~C~, mult.   *δ*~H~ (J in Hz)
  ------ --------------- ------------------ ----------- --------------- -----------------------------
  1      140.0, C                           5′′         128.4, CH       7.43, t (7.5)
  2      130.3, CH       7.62, d (7.5)      6′′         131.5, CH       7.46, d (7.5)
  3      128.4, CH       7.40, t (7.5)      1′′′        104.6, CH       4.81, d (7.7)
  4      127.6, CH       7.32, t (7.5)      2′′′        75.3, CH        3.24, obsc.
  5      128.4, CH       7.40, t (7.5)      3′′′        77.5, CH        3.33, td (8.8, 3.3)
  6      130.3, CH       7.62, d (7.5)      4′′′        71.0, CH        3.24, obsc.
  1′     137.3, C                           5′′′        76.9, CH        3.05 , ddd (9.5, 4.7, 3.1)
  2′     140.7, C                           6′′′        62.3, CH~2~     3.53 , ddd (11.4, 5.8, 3.1)
  3′     152.3, C                                                       3.43, ddd (11.4, 7.3, 4.7)
  4′     124.0, C                           3′-OCH~3~   61.3, CH~3~     3.59, s
  5′     151.8, C                           5′-OH                       7.94, s
  6′     112.9, CH       6.76, s            2′′′-OH                     4.10, obsc.
  1′′    135.0, C                           3′′′-OH                     4.10, obsc.
  2′′    131.5, CH       7.46, d (7.5)      4′′′-OH                     4.04, d (3.3)
  3′′    128.4, CH       7.43, t (7.5)      6′′′-OH                     2.19, dd (7.3, 5.8)
  4′′    127.6, CH       7.34, t (7.5)                                  
